Increased IGF2 expression was detected in inactive demyelinated lesions when compared to normal appearing white matter, but significantly reduced in remyelinating lesions in comparison to inactive demyelinated lesions in post mortem tissues of MS patients, suggesting that IGF2 among other genes in inactive demyelinated lesions could initiate and/or support remyelination [108]. Here, IGF2 is linked to myeloid sarcoma.